Biotech

All Articles

Basilea credit ratings $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work developing new antifungals has actually gotten a substantial improveme...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Having actually gathered up the USA civil rights to Capricor Rehabs' late-stage Duchenne muscular d...

FDA junks adcomm for Applied's uncommon condition drug

.After pushing the selection meeting for Applied Therapies' metabolic problem medication govorestat,...

Novo inks $600M NanoVation deal to research genetic medicines ex-liver

.Novo Nordisk is actually continuing its push into genetic medicines, agreeing to compensate NanoVat...

Innovent links cytokine to intestines cancer cells feedbacks

.Innovent Biologics has made the situation that its own gate inhibitor-cytokine combination healthy ...

Merck, Daiichi ADC reaches target in phase 3 lung cancer study

.A stage 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina strengthens artificial intelligence center with collab to choose cancer targets

.5 months after Rakovina Therapies pivoted toward artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug smash hits in stage 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential risk to BioMarin's Voxzogo, reporting period 3 ...

Despite ph. 3 miss, Alkeus observes road ahead for eye ailment property

.Though Alkeus Pharmaceuticals' oral eye ailment possession neglected to substantially reduce geogra...

Kairos goes social with $6M IPO to cash trials of cancer drug

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was simple to miss out on a smaller...